Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial

BMJ (Online)

Volumn 348, Issue , 2014, Pages

  Jørgensen, Torben ^a,b,c   Jacobsen, Rikke Kart ^a   Toft, Ulla ^a   Aadahl, Mette ^a   Glümer, Charlotte ^a,c   Pisinger, Charlotta ^a,b  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c AALBORG UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIET; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; PATIENT COUNSELING; PHYSICAL ACTIVITY; POPULATION RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SMOKING CESSATION; THERAPY EFFECT;

ADULT; DIRECTIVE COUNSELING; FEMALE; HUMANS; INCIDENCE; LIFE STYLE; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA;

EID: 84902308398     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g3617     Document Type: Article

References (57)

1. World Health Organization. European health report: health and health systems. WHO, 2009.
2. Stamler J, Stamler R, Neaton JD, Wentworth D, Daviglus ML, Garside D, et al. Low risk-factor profile and long-term cardiovascular and non-cardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. JAMA 1999;282:2012-8.
3. Hjermann I, Holme I, Leren P. Oslo Study Diet and Antismoking Trial: results after 102 months. Am J Med 1986;80:7-11. (Pubitemid 16131297)
4. Ebrahim S, Davey Smith G. A systematic review and meta-analysis of randomised controlled trials of health promotion for prevention of coronary heart disease in adults. BMJ 1997;314:1666-74. (Pubitemid 27232040)
5. Multiple Risk Factor Intervention Trial Research Group. Mortality rates after 10.5 years for participants in the Multiple Risk Factor Intervention Trial: findings related to a priori hypotheses of the trial. JAMA 1990;263:1795-801.
6. Jørgensen T, Borch-Johnsen K, Thomsen TF, Ibsen H, Glümer C, Pisinger C. A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99 (1). Eur J Cardiovasc Prev Rehabil 2003;10:377-86. (Pubitemid 38037253)
7. Wood D, Backer GD, Faergeman O, Graham I, Mancia G, Pyörä lä K. Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis 1998;140:199-270. (Pubitemid 28535317)
8. Schroll M, Larsen S. A ten-year prospective study, 1964-1974, of cardiovascular risk factors in men and women from the Glostrup population born in 1914: multivariate analyses. Dan Med Bull 1981;28:236-51. (Pubitemid 12137096)
9. Truelsen T, Lindenstrøm E, Boysen G. Comparison of probability of stroke between Copenhagen City Heart Study and the Framingham Study. Stroke 1994;25:802-7. (Pubitemid 24111327)
10. Justice AC, Covinsky KE, Berlin JA. Assessing the generalizability of prognostic information. Ann Intern Med 1999;130:515-24. (Pubitemid 29135805)
11. Thomsen T, Davidsen M, Ibsen H, Jørgensen T, Jensen G, Borch-Johnsen K. A new method for CHD prediction and prevention based on regional risk scores and randomized clinical trials: PRECARD and the Copenhagen Risk Score. J Cardiovasc Risk 2001;8:291-7. (Pubitemid 33010689)
12. Thomsen TF, McGee D, Davidsen M, Jørgensen T. A cross validation of risk-scores for CHD mortality based on data from the Glostrup Population Studies and Framingham Heart Study. Int J Epidemiol 2002;31:817-22. (Pubitemid 34947251)
13. Collin R, Peto R, MacMahon S, Herbert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke, and coronary heart disease: part 2. Short term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827-38. (Pubitemid 20113741)
14. Thomsen T. HeartScore: a new web-based approach to European cardiovascular disease risk management. Eur J Cardiovasc Prev Rehabil 2005;12:424-6. (Pubitemid 44966785)
15. Pisinger C, Glümer C, Toft U, von Huth Smith L, Aadahl M, Borch-Johnsen K, et al. High risk strategy in smoking cessation is feasible on a population-based level: the Inter99 study. Prev Med 2008;46:579-84.
16. Toft U, Kristoffersen L, Ladelund S, Ovesen L, Lau C, Borch-Johnsen K, et al. The impact of a population-based multi-factorial lifestyle intervention on changes in long-term dietary habits: the Inter99 study. Prev Med 2008;47:378-83.
17. Smith LV, Ladelund S, Borch-Johnsen K, Jørgensen T. A randomized multifactorial intervention study for prevention of ischaemic heart disease (Inter99): the long-term effect on physical activity. Scand J Public Health 2008;36:380-8. (Pubitemid 351796241)
18. Aadahl M, von Huth Smith L, Toft U, Pisinger C, Jørgensen T. Does a population-based multifactorial lifestyle intervention increase social inequality in physical activity? Br J Sport Med 2011;45:209-15.
19. Toft U, Pisinger C, Aadahl M, Lau C, Linneberg A, Ladelund S, et al. The impact of a population-based multi-factorial lifestyle intervention on alcohol intake: the Inter99 study. Prev Med 2009;49:115-21.
20. Pisinger C, Toft U, Aadahl M, Glümer C, Jørgensen T. The relationship between lifestyle and self-reported health in a general population: the Inter99 study. Prev Med 2009;49:418-23.
21. Wilson JMG, Jungner G. Principles and practice of screening for disease. World Health Organization, 1968.
22. Kramer BS, Gohagan JK, Prorok PC. Cancer screening: theory and practice. CRC Press, 1999.
23. Janz NK, Becker MH. The health belief model: a decade later. Health Educ Q 1984;11:1-47.
24. Bandura A. Social foundation of thoughts and action: a social cognitive theory. Prentice Hall, 1986.
25. Prochaska JO, DiClemente CC, Norcross JC. In search of how people change: application to addictive behaviours: readings on etiology, prevention, and treatment. American Psychological Association, 1997:671-96.
26. Burke BL, Arkowitz H, Menchola M. The efficacy of motivational interviewing: a meta analysis of controlled trials. J Consult Clin Psychol 2003;71:843-61. (Pubitemid 37151548)
27. Lynge E, Sandegaard JL, Rebolj M. The Danish national patient register. Scand J Public Health 2011;39(suppl 7):30-3.
28. Andersen PK, Geskus RB, deWitte T, Putter H. Competing risks in epidemiology: possibilities and pitfalls. Int J Epidemiol 2012;41:861-70
29. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of competing risk. Ann Stat 1988;16:1141-54.
30. Jørgensen T, Ladelund S, Borch-Johnsen K, Pisinger C, Schrader AM, Thomsen T, et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Prev Med 2009;48:242-6.
31. Wilhelmsen L, Berglund G, Elmfeldt D, Tibblin G, Wedel H, Pennert K, et al. The multifactor primary prevention trial in Göteborg, Sweden. Eur Heart J 1986;7:279-88. (Pubitemid 16120809)
32. Lightwood JM, Glantz SA. Declines in acute myocardial infarction after smoke-free laws and individual risk attributable to secondhand smoke. Circulation 2009;120:1373-9.
33. Ebrahim S, Taylor F, Ward K, Beswick A, Burke M, Davey Smith G. Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database Syst Rev 2011;(1):CD001561.
34. Prentice RL, Caan B, Chlebowski RT, Patterson R, Kuller LH, Ockene JK. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006;295:629-42. (Pubitemid 43209065)
35. Beresford SA, Johnson KC, Ritenbaugh C, Lasser NL, Snetselaar LG, Black HR, et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006;295:643-54. (Pubitemid 43209066)
36. Krogsbøll LT, Jørgensen KJ, Grønhøj Larsen C, Gøtzsche PC. General health check in adults for reducing morbidity and mortality from disease. Cochrane Database Syst Rev 2012;(10):CD009009.
37. McCartney M. Where's the evidence for NHS health checks? BMJ 2013;347:f5834.
38. Rees K, Dyakova M, Ward K, Thorogood M, Brunner E. Dietary advice for reducing cardiovascular risk. Cochrane Database Syst Rev 2013;(3):CD002128.
39. Bender AM, Jørgensen T, Hansen BH, Linneberg A, Pisinger C. Socioeconomic position and participation in baseline and follow-up visits: the Inter99 study. Eur J Prev Cardiol 2012; published online 11 Dec.
40. Grace SL, Abbey SE, Shnek ZM, Irvine J, Franche RL, Stewart DE. Cardiac rehabilitation II: referral and participation. Gen Hosp Psychiatry 2002;24:127-34, (Pubitemid 34406423)
41. Frederiksen BL, Jorgensen T, Brasso K, Holten I, Osler M. Socioeconomic position and participation in colorectal cancer screening. Br J Cancer 2010;103:1496-501.
42. Holme I, Hjermann I, Helgeland A, Leren P. The Oslo study: diet and antismoking advice: additional results from a 5-year primary preventive trial in middle-aged men. Prev Med 1985;14:279-92. (Pubitemid 15239670)
43. Saidj M, Jørgensen T, Prescott E, Borglykke A. Poor predictive ability of the risk chart SCORE in a Danish population. Dan Med J 2013;60:A4609.
44. Jørgensen T, Capewell S, Prescott E, Allender S, Sans S, Zdrojewski T, et al. Population-level changes to promote cardiovascular health. Eur J Prev Cardiol 2013;20:409-21.
45. Franco M, Ordunez P, Caballero B, Tapia-Granados JA, Lazo M, Bernal JL, et al. Impact of energy intake, physical activity, and population-wide weight loss on cardiovascular disease and diabetes mortality in Cuba, 1980-2005. Am J Epidemiol 2007;166:1374-80. (Pubitemid 350209043)
46. Zatonski WA, McMichael AJ, Powles JW. Ecological study of reasons for sharp decline in mortality from ischaemic heart disease in Poland since 1991. BMJ 1998;316:1047-51. (Pubitemid 28143101)
47. Rose G. The strategy of preventive medicine. Oxford University Press, 1992.
48. Cooney MT, Dudina A, Whincup P, Capewell S, Menotti A, Jousilahti P, et al. Re-evaluating the Rose approach: comparative benefits of the population and high-risk preventive strategies. Eur J Cardiovasc Prev Rehabil 2009;16:541-9.
49. Wiist WH. The bottom line or public health: tactics corporations use to influence health and health policy, and what we can do to counter them. Oxford University Press, 2010.
50. Jahiel RI, Babor TF. Industrial epidemics, public health advocacy and the alcohol industry: lessons from other fields. Addiction 2007;102:1335-9. (Pubitemid 47246982)
51. Proctor RN. The golden holocaust: origins of the cigarette catastrophe and the case of abolition. University of California Press, 2011.
52. Chan M. WHO Director-General addresses health promotion conference. 2013. www.who.int/dg/speeches/2013/health-promotion-20130610/en/.
53. Stuckler D, Basu S, McKee M. Commentary: UN high level meeting on non-communicable diseases: an opportunity for whom? BMJ 2011;343:d5336.
54. Ding A. Curbing adolescent smoking: a review of the effectiveness of various policies. Yale J Biol Med 2005;78:37-44.
55. Wagenaar AC, Salois MC, Komro KA. Effects of beverage alcohol price and tax levels on drinking: a meta-analysis of 1003 estimates from 112 studies. Addiction 2009;104:179-90.
56. He FJ, MacGregor GA, A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens 2009;23:363-84.
57. Estruch R, Ros E, Salas-Salvadó J, Covas MI, Corella D, Arós F, et al, for the PREDIMED Study Investigators. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013;368:1279-90.